Employer profile
Karyopharm Therapeutics
9 certified H-1B filings across 6 fiscal years.
FY2025 filings
2
FY2025 median
$133k
Top role
Associate Director, Xpovio U.S. Multiple Myeloma Marketing
1 filings
Top state
MA
5 filings
Karyopharm Therapeutics has filed 9 certified H-1B Labor Condition Applications over FY2020–FY2026. In FY2025, its median certified base salary was $133k ($133k–$140k interquartile range). The most-filed role is Associate Director, Xpovio U.S. Multiple Myeloma Marketing (1 filings).
Year-over-year
How Karyopharm Therapeutics hired across H-1B fiscal years. YoY column compares to the prior FY.
| FY | Filings | Median $ | YoY % |
|---|---|---|---|
| FY2026 | 1 | $153k | -50 |
| FY2025 | 2 | $133k | +100 |
| FY2023 | 1 | $160k | 0 |
| FY2022 | 1 | $170k | 0 |
| FY2021 | 1 | $170k | -67 |
| FY2020 | 3 | $130k | — |
Top job titles
Most-filed positions, across all years (raw DOL titles).
| Job Title | Filings | Median |
|---|---|---|
| Associate Director, Xpovio U.S. Multiple Myeloma Marketing | 1 | $165k |
| Associate Director/Director, Clinical Pharmacology And Dmpk | 1 | $170k |
| Manager, Regulatory Operations | 1 | $140k |
| Principal Scientist | 1 | $120k |
| Senior Associate, Regulatory Operations | 1 | $130k |
| Senior Clinical Data Manager | 1 | $133k |
| Sr Scientist, Analytical Chemistry | 1 | $153k |
| Sr. Clinical Trial Manager | 1 | $160k |
Top worksite states
Where this employer files.
| State | Filings | Median |
|---|---|---|
| MA | 5 | $153k |
| AR | 1 | $133k |
| CA | 1 | $170k |
| NC | 1 | $140k |
| PA | 1 | $170k |
Prevailing wage level distribution
DOL Levels I–IV approximate experience tiers (I = entry, IV = fully competent). A heavy Level I/II skew suggests entry-level / contractor-style hiring; a heavy IV skew suggests senior in-house roles.
Lvl II
111%
Lvl III
222%
Lvl IV
667%
Frequently asked questions
- Does Karyopharm Therapeutics sponsor H-1B visas?
- Yes. Karyopharm Therapeutics has filed 9 certified H-1B Labor Condition Applications (LCAs) over FY2020–FY2026. An LCA is a required step before an employer files an H-1B petition; a certified LCA does not by itself guarantee an approved visa.
- What is the median H-1B salary at Karyopharm Therapeutics?
- In FY2025, the median certified H-1B base salary at Karyopharm Therapeutics was $133k, with a 25th–75th percentile range of $133k–$140k. This is the annual base wage stated on the LCA and excludes bonus, equity, and other compensation.
- What jobs does Karyopharm Therapeutics hire H-1B workers for?
- Karyopharm Therapeutics's most-filed H-1B role is Associate Director, Xpovio U.S. Multiple Myeloma Marketing (1 filings), followed by Associate Director/Director, Clinical Pharmacology And Dmpk (1). Its top worksite state is MA.
- How many H-1B filings did Karyopharm Therapeutics submit in FY2025?
- Karyopharm Therapeutics had 2 certified H-1B LCA filings in FY2025 — a 100% increase from the prior fiscal year.